Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors-Reference-Cited by-同舟云学术

Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors

Published:1995-02 Issue:2 Volume:6 Page:133-140
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Catimel G.,Chabot G.G.,Guastalla J.P.,Dumortier A.,Cote C.,Engel C.,Gouyette A.,Mathieu-Boué A.,Mahjoubi M.,Clavel M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/6/2/133/494294/6-2-133.pdf

Reference38 articles.

1. Plant antitumor agents I;Wall;The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J Am Chem Soc,1966

2. Lethal activity of camptothecin sodium on human lymphoma cells;Drewinko;Cancer Res,1974

3. Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin;Gallo;J Natl Cancer Inst,1971

4. Toxicity of camptothecin (NSC 100880);Schaeppi;Cancer Chemother Rep,1974

5. Phase I clinical trial of weekly and daily treatment with camptothecin (NSC 100880): Correlation with preclinical studies;Muggia;Cancer Chemother Rep,1972

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Analysis of a Fractional-Order Model of Colorectal Cancer and the Chemo-Immunotherapeutic Treatments with Monoclonal Antibody;Mathematics;2023-05-19

2. Population pharmacokinetic model of irinotecan and its four main metabolites in patients treated with FOLFIRI or FOLFIRINOX regimen;Cancer Chemotherapy and Pharmacology;2021-04-28

3. Seaweeds: Potential Candidates in Human Colon Cancer Therapy;Colon Cancer Diagnosis and Therapy;2021

4. Intestinal bacterial β-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severity;Pharmacology & Therapeutics;2019-07

5. Topoisomerase Inhibitors and Targeted Delivery in Cancer Therapy;Current Topics in Medicinal Chemistry;2019-06-20